Rockefeller Capital Management L.P. Abb Vie Inc. Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 829,877 shares of ABBV stock, worth $151 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

829,877

Previous 812,960 2.08%

Holding current value

$151 Million

Previous $139 Million 17.53%

% of portfolio

0.45%

Previous 0.4%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $2.77 Million - $3.37 Million	16,917 Added 2.08%	829,877 $164 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $2.25 Million - $2.62 Million	14,508 Added 1.82%	812,960 $139 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $9 Million - $10.3 Million	56,328 Added 7.59%	798,452 $145 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $8.75 Million - $9.86 Million	63,616 Added 9.38%	742,124 $115 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $6.39 Million - $7.39 Million	47,800 Added 7.58%	678,508 $101 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $824,212 - $1.03 Million	6,220 Added 1.0%	630,708 $85 Million
Q1 2023 May 17, 2023	SELL	$144.61 - $166.54 $2.35 Million - $2.71 Million	-16,261 Reduced 2.54%	624,488 $99.5 Million
Q4 2022 Mar 06, 2023	SELL	$138.31 - $165.87 $206,220 - $247,312	-1,491 Reduced 0.23%	640,749 $104 Million
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $18.5 Million - $21.2 Million	137,854 Added 27.33%	642,240 $86.2 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $10.3 Million - $13.1 Million	74,757 Added 17.4%	504,386 $77.3 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $1.09 Million - $1.36 Million	8,281 Added 1.97%	429,629 $69.6 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $1.76 Million - $2.23 Million	16,429 Added 4.06%	421,348 $57 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $5.43 Million - $6.17 Million	51,054 Added 14.43%	404,919 $43.7 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $6.5 Million - $7.24 Million	61,752 Added 21.14%	353,865 $39.9 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $2.29 Million - $2.52 Million	22,357 Added 8.29%	292,113 $31.6 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $3.27 Million - $4.42 Million	40,665 Added 17.75%	269,756 $28.9 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $3.32 Million - $3.9 Million	38,689 Added 20.32%	229,091 $20.1 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $2.3 Million - $3.08 Million	31,350 Added 19.71%	190,402 $18.7 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $1.53 Million - $2.32 Million	23,739 Added 17.54%	159,052 $12.1 Million
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $3.36 Million - $4.2 Million	46,515 Added 52.38%	135,313 $12 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $1.99 Million - $2.4 Million	31,639 Added 55.35%	88,798 $6.72 Million
Q2 2019 Aug 09, 2019	SELL	$65.7 - $83.98 $266,019 - $340,035	-4,049 Reduced 6.62%	57,159 $4.16 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $621,516 - $731,495	8,057 Added 15.16%	61,208 $4.93 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $1.02 Million - $1.26 Million	13,156 Added 32.89%	53,151 $4.9 Million
Q3 2018 Nov 02, 2018	SELL	$88.91 - $98.84 $178,175 - $198,075	-2,004 Reduced 4.77%	39,995 $3.78 Million
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $20,290 - $24,007	226 Added 0.54%	41,999 $3.89 Million
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $3.84 Million - $5.15 Million	41,773 New	41,773 $3.95 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $321B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Abb Vie Inc. Transaction History